FindTrial
Sign In

Comparison of effect of Hingwadi tablet and Dicyclomine-Mefenamic acid tablet in pain during periods.

A randomized controlled clinical trial to evaluate the efficacy of Hingwadi vati versus Dicyclomine Mefenamic acid combination in the management of Kashtartava with special reference to Primary Dysmenorhhea. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106532
Enrollment
120
Registered
2026-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Institute for Ayurveda Studies and Research SKAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering with Kashtartava (Primary dysmenorrhea) since more than 2 consecutive cycles. Patients with Visual Analogue Scale Score 4 or higher. Patient with history of using any type of analgesics during menses. Patients having regular menstrual cycles.

Exclusion criteria

Exclusion criteria: Patient suffering from secondary dysmenorrhea with any detectable pelvic pathology i.e. PID, PCOD, Cervical stenosis, Fibroid, Endometriosis, DUB, Adenomyosis, Endometrial polyp, Carcinoma of endometrium, etc. Patient suffering from sexually transmitted infections. Patient suffering from systemic diseases. Patient taking any hormonal therapy. Patient with congenital anomalies of reproductive system. Patient with hemoglobin less than 8 gm%.

Design outcomes

Primary

MeasureTime frame
To study the effect of Hingwadi vati 250 mg BID for 2 consecutive menstrual cycles in the management of Kastartava w.s.r to Primary Dysmenorrhea.Timepoint: 2 months with follow up on 5th day of each menstrual cycle—

Secondary

MeasureTime frame
To assess the efficacy of Dicyclomine-Mefenamic Acid combination 250 mg BID in the management of clinical features of Kashtartava w.s.r to Primary Dysmenorrhea. Timepoint: 2 months with follow up on 5th day of each menstrual cycle;To compare the efficacy of Hingwadi Vati & Dicyclomine- Mefenamic Acid combination. Timepoint: 2 months with follow up on 5th day of each menstrual cycle;To evaluate the efficacy of trial drugs on QOL by SF-12.Timepoint: 2 months with follow up on 5th day of each menstrual cycle.—

Countries

India

Contacts

Public ContactDr Neha Singh

Institute for Ayurveda Studies and Research SKAU Sector 8 Umri Road Kurukshetra Haryana

drjk67@gmail.com9896033056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026